Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Concurrence of osteonecrosis and steroid myopathy secondary to oral steroid therapy in a patient with ABCB1 gene polymorphisms: A case report

7 Oct 2022

Abstract excerpt

Glucocorticoids (GCs) are widely used in various autoimmune diseases. Side effects may occur in patients with long-term or high-dose GC usage. Among them, steroid myopathy and osteonecrosis are two severe forms. We report a patient with pemphigus vulgaris on GC-treatment who developed muscle weakness when a cumulative dose of methylprednisolone reached about 20g (14-80mg/d for 2.5 years). Laboratory tests showed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone and Joint Diseases
Share to Bone health and treatments
Share to Parvovirus B19 Infection Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36277691
DOI: 10.3389/fendo.2022.1016687

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 11 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Concurrence of osteonecrosis and steroid myopathy secondary to oral steroid therapy in a patient with ABCB1 gene polymorphisms: A case reportPMID 36277691Read ↗

The pathogenesis, diagnosis and clinical manifestations of steroid-induced osteonecrosis.Semantic proximity Read ↗

Genetic risk factors for glucocorticoid-induced osteonecrosis: a meta-analysis.Semantic proximity Read ↗

Association of ABCB1/MDR1 polymorphisms in patients with glucocorticoid-induced osteonecrosis of the femoral head: Evidence for a meta-analysis.Semantic proximity Read ↗

Etoricoxib as a treatment of choice for patients with SLCO2A1 mutation exhibiting autosomal recessive primary hypertrophic osteoarthropathy: A case reportSemantic proximity Read ↗

Current concepts on the pathogenesis and natural history of steroid-induced osteonecrosis.Semantic proximity Read ↗

Fasciitis-panniculitis syndrome with autoantibodies reacting to collagen fibers: A case reportSemantic proximity Read ↗

Clinical Value of ABCB1 and PAI-1 Gene Polymorphisms in Predicting Glucocorticoid-induced Adverse Reactions in Nephrotic Syndrome Patients.Semantic proximity Read ↗

Complicating autoimmune diseases in myasthenia gravis: a review.Semantic proximity Read ↗

Genetic association of the P-glycoprotein gene ABCB1 polymorphisms with the risk for steroid-induced osteonecrosis of the femoral head in Chinese population.Semantic proximity Read ↗

Promising effect of intravenous immunoglobulin therapy for epidermolysis bullosa pruriginosa.Semantic proximity Read ↗

Genetic Background of Medication-Related Osteonecrosis of the Jaw: Current Evidence and Future Perspectives.Semantic proximity Read ↗

Severe Vancomycin-Induced IgA Bullous Dermatosis Case ReportSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.